Barclays and Evercore Stay Positive on Danaher (DHR) Despite Cutting Price Targets

The probe steadfast adjusted terms targets for the beingness sciences and diagnostic tools assemblage arsenic portion of its first-quarter preview. While Barclays remains affirmative astir the wide setup for the sector, it noted that it is “not without risk.” The steadfast besides highlighted that capitalist sentiment is astatine all-time debased levels but it continues to enactment the “last-cut thesis (for the astir part).”

Earlier, connected April 6, Evercore ISI expert Vijay Kumar besides chopped the firm’s terms people connected Danaher Corporation (NYSE:DHR) from $254 to $225 and maintained an Outperform standing connected the stock.

Danaher Corporation (NYSE:DHR) was besides added to Evercore ISI’s “Tactical Outperform” database arsenic portion of the firm’s Q1 preview for aesculapian exertion and beingness subject tools companies.

Danaher Corporation (NYSE:DHR) is simply a starring planetary beingness sciences and diagnostics innovation company. The institution is known for its professional, medical, research, and concern products and services that assistance discover, develop, and present life-changing therapies.

While we admit the imaginable of DHR arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Performing AI Stocks to Buy and 10 Best Performing Blue Chip Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.